Prognostic significance of early lymphocyte recovery after post-autografting administration of GM-CSF in non-Hodgkin's lymphoma

Bone Marrow Transplantation

Volumn 40, Issue 7, 2007, Pages 671-675

  Tiwari, D ^a   Gao, F ^a   Hidalgo, J ^a   Adkins, D R ^a   Vij, R ^a   DiPersio, J F ^a   Khoury, H J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CARMUSTINE; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN; MESNA; METHYLPREDNISOLONE SODIUM SUCCINATE; MITOXANTRONE; PLATINUM COMPLEX; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RITUXIMAB;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER RELAPSE; CANCER SURVIVAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEUTROPENIC ENTEROCOLITIS; NONHODGKIN LYMPHOMA; OUTCOMES RESEARCH; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEX RATIO; STEM CELL MOBILIZATION; THROMBOCYTE COUNT;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD34; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUTROPENIA; PLATELET TRANSFUSION; PROGNOSIS; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 34648837868     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705795     Document Type: Article

References (17)

1. Phillip T, Guglielmi C, Hagenbeek A, Somers R, Vander Lelie H, Bron D et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapse of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540-1545.
2. Philip T, Biron P. High-dose chemotherapy and autologous bone marrow transplantation in diffuse intermediate- and high-grade non-Hodgkin lymphoma. Crit Rev Oncol Hematol 2002; 41: 213-223.
3. Porrata LF, Gertz MA, Inwards DJ, Litzow MR, Lacy MQ, Tefferi A et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin's lymphoma. Blood 2001; 98: 579-585.
4. Yoong Y, Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Litzow MR et al. The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma. Leuk Lymphoma 2005; 46: 1287-1294.
5. Gordan LN, Sugrue MW, Lynch JW, Williams KD, Khan SA, Moreb JS et al. Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma. Bone Marrow Transplant 2003; 31: 1009-1013.
6. Porrata LF, Inwards DJ, Micallef IN, Ansell SM, Geyer S, Markovic SN. Early lymphocyte recovery post autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's lymphoma. Br J Haematol 2002; 117: 629-633.
7. Porrata LF, Litzow MR, Tefferi A, Letendre L, Kumar S, Geyer SM et al. Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia 2002; 16: 1311-1318.
8. Nieto Y, Shpall EJ, McNiece IK, Nawaz S, Beaudet J, Rosinski S et al. Prognostic analysis of the early lymphocyte recovery in patients with advanced breast cancer receiving high-dose chemotherapy with an autologous hematopoietic progenitor cell transplant. Clin Cancer Res 2004; 10: 5076-5086.
9. Porrata LF, Ingle JN, Litzow MR, Geyer S, Markovic SN. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. Bone Marrow Transplant 2001; 28: 865-871.
10. Tarella C, Castellino C, Locatelli C. G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: Evidence for clinical benefits and reduction of treatment costs. Bone Marrow Transplant 1998; 21: 401-407.
11. Uyl-de Groot CA, Huijgens PC, Rutten FF. Colony-stimulating factors and peripheral blood progenitor cell transplantation: Benefits and costs. Pharmacoeconomics 1996; 10: 23-35.
12. Pagliuca A, Carrington PA, Pettengell R, Tule S, Keidan J. Haemato-oncology task force of the British Committee for Standards in Haematology. Guidelines on the use of colony-stimulating factors in haematological malignancies. Br J Haematol 2003; 123: 22-33.
13. Gore SD, Donnenberg AD, Zehnbauer BA. Granulocyte - macrophage colony-stimulating factor (GM-CSF), given concurrently with induction therapy for acute myelogenous leukemia (AML), augments the syndrome of T-lymphocyte recovery. Leukemia 1994; 8: 409-419.
14. Setti M, Bignardi D, Ballestrero A, Ferrando F, Musselli C, Blanchi S et al. The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor and granulocyte/macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer. Cancer Immunol Immunother 1999; 48: 287-296.
15. Hoerr A, Feng G, Hidalgo J, Tiwari D, Blue KA, Mathews V et al. Effects of pre-transplant treatment with rituximab on outcomes of autologous stem cell transplantation for non-Hodgkin's lymphoma. J Clin Oncol 2004; 22: 4561-4566.
16. Porrata LF, Litzow MR, Inwards DJ, Gastineau DA, Moore SB, Pineada AA et al. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant 2004; 33: 291-298.
17. Porrata LF, Gastineau DA, Padley D, Bundy K, Markovic SN. Re-infused autologous graft natural killer cells correlates with absolute lymphocyte count recovery after autologous stem cell transplantation. Leuk Lymphoma 2003; 44: 997-1000.